购物车
- 全部删除
- 您的购物车当前为空
ML-210 (CID 49766530) 是一种谷胱甘肽过氧化物酶 4 (GPX4) 抑制剂 (EC50=30 nM),具有共价性和选择性。ML-210 具有抗肿瘤活性,可诱导铁死亡。
为众多的药物研发团队赋能,
让新药发现更简单!
ML-210 (CID 49766530) 是一种谷胱甘肽过氧化物酶 4 (GPX4) 抑制剂 (EC50=30 nM),具有共价性和选择性。ML-210 具有抗肿瘤活性,可诱导铁死亡。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 327 | 现货 | |
2 mg | ¥ 465 | 现货 | |
5 mg | ¥ 745 | 现货 | |
10 mg | ¥ 1,330 | 现货 | |
25 mg | ¥ 2,320 | 现货 | |
50 mg | ¥ 3,990 | 现货 | |
100 mg | ¥ 5,220 | 现货 | |
200 mg | ¥ 7,690 | 现货 | |
500 mg | ¥ 11,300 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 778 | 现货 |
产品描述 | ML-210 (CID 49766530) is a glutathione peroxidase 4 (GPX4) inhibitor (EC50=30 nM) that is covalent and selective. ML-210 has antitumor activity and induces ferroptosis. |
靶点活性 | GPX4:30 nM(EC50) |
体外活性 | 方法: 人肺腺癌细胞系 HCC4006 用 ML-210 (10 µM) 处理 1 h,使用 Western Blot 检测 CETSA 图谱。 结果: ML-210 影响 GPX4 的热稳定性,与细胞靶标结合一致。[1] 方法: DRD 细胞系用 ML-210 处理 48 h,检测细胞活力。 结果: ML-210 在 DRD 细胞系中具有 107 nM 的 IC50。[2] |
别名 | CID 49766530 |
分子量 | 475.32 |
分子式 | C22H20Cl2N4O4 |
CAS No. | 1360705-96-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 11 mg/mL (23.14 mM) 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1.1 mg/mL (2.31 mM), Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
10% DMSO+40% PEG300+5% Tween 80+45% Saline/DMSO
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.